Dimensional Fund Advisors LP Sells 23,118 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Dimensional Fund Advisors LP trimmed its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,652,062 shares of the company’s stock after selling 23,118 shares during the quarter. Dimensional Fund Advisors LP owned about 7.37% of Prestige Consumer Healthcare worth $217,041,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Advisor Group Holdings Inc. increased its position in Prestige Consumer Healthcare by 10.9% in the first quarter. Advisor Group Holdings Inc. now owns 3,694 shares of the company’s stock worth $196,000 after purchasing an additional 363 shares during the period. JPMorgan Chase & Co. raised its position in shares of Prestige Consumer Healthcare by 10.8% during the 1st quarter. JPMorgan Chase & Co. now owns 210,242 shares of the company’s stock valued at $11,130,000 after acquiring an additional 20,496 shares during the last quarter. Raymond James & Associates raised its position in shares of Prestige Consumer Healthcare by 84.8% during the 1st quarter. Raymond James & Associates now owns 9,326 shares of the company’s stock valued at $494,000 after acquiring an additional 4,279 shares during the last quarter. US Bancorp DE lifted its stake in shares of Prestige Consumer Healthcare by 67.7% in the 1st quarter. US Bancorp DE now owns 10,237 shares of the company’s stock valued at $541,000 after purchasing an additional 4,132 shares during the period. Finally, HighTower Advisors LLC grew its stake in shares of Prestige Consumer Healthcare by 6.0% during the first quarter. HighTower Advisors LLC now owns 5,791 shares of the company’s stock worth $307,000 after purchasing an additional 330 shares during the period. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

Shares of Prestige Consumer Healthcare stock opened at $59.01 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.99 and a quick ratio of 1.75. The firm has a market cap of $2.93 billion, a price-to-earnings ratio of -35.55, a price-to-earnings-growth ratio of 1.70 and a beta of 0.57. The stock’s 50-day moving average is $58.79 and its 200-day moving average is $59.54. Prestige Consumer Healthcare Inc. has a one year low of $55.96 and a one year high of $68.54.

Insider Buying and Selling at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 2,540 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $58.92, for a total value of $149,656.80. Following the sale, the senior vice president now owns 15,934 shares of the company’s stock, valued at $938,831.28. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on PBH. StockNews.com cut Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Monday, November 6th. BMO Capital Markets lowered their target price on shares of Prestige Consumer Healthcare from $124.00 to $117.00 and set an “outperform” rating for the company in a research note on Wednesday. Royal Bank of Canada cut their target price on shares of Prestige Consumer Healthcare from $110.00 to $103.00 and set a “sector perform” rating on the stock in a report on Wednesday. Finally, TheStreet cut shares of Prestige Consumer Healthcare from a “b” rating to a “c+” rating in a research report on Thursday, September 7th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $90.50.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.